Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell Therapeutics
Pharma
Gilead's Kite exits China cell therapy JV with Fosun Pharma
Kite’s exit from the Fosun JV comes as CAR-T meds continue to navigate patient access and reimbursement dynamics in China.
Angus Liu
Sep 19, 2024 4:23pm
FDA signs off on first engineered cell therapy for a solid tumor
Aug 2, 2024 8:56am
Bristol Myers’ top challenges, as seen by analysts
Jul 12, 2024 12:00pm
J&J, Legend's Carvykti extends lives in multiple myeloma trial
Jul 2, 2024 9:58am
ASCO: BMS' triplet, Iovance's Amtagvi-Keytruda target melanoma
May 23, 2024 5:00pm
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
May 16, 2024 10:56am
